Treating Co-Occurring Substance Use and Mental Disorders Among Jail Inmates

March 13, 2020 updated by: RTI International
Treatment adaptation and implementation study for adult jail inmates with co-occurring substance use disorders.

Study Overview

Detailed Description

We will adapt dual-diagnosis motivational interviewing and integrated group therapy for jail inmates with co-occurring substance use and mental health disorders and to evaluate the feasibility of implementing the adapted interventions and associated research and communication protocols.

Study Type

Interventional

Enrollment (Actual)

8

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Research Triangle Park, North Carolina, United States, 27709
        • RTI International

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • (1) drug or alcohol abuse or dependence and SMI (major depressive disorder; depressive disorder not otherwise specified [NOS]; bipolar disorder I, II, or NOS; schizophrenia spectrum disorder; schizoaffective disorder; schizophreniform disorder; brief psychotic disorder; delusional disorder; or psychotic disorder NOS);
  • (2) resident of Wake County and detained in The Jail;
  • (3) >18 years of age; (4) able to speak/read English; and (5) able to provide informed consent.

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: DDMI-IGT
Subjects randomized to the experimental condition will receive adapted versions of dual-diagnosis motivational interviewing ([DDMI] one session before release from jail) and integrated group therapy ([IGT] 12 community-based sessions over a 2-month period).
DDMI is an evidence-based adaptation to motivational interviewing. DDMI incorporates an integrated framework and accommodates cognitive impairments and disordered thinking associated with co-occurring substance use and mental disorders.
IGT is an evidence-based practice for treating co-occurring disorders. IGT focuses on relapse prevention by reducing substance use and stabilizing psychiatric symptoms.
Active Comparator: Usual care
Subjects randomized to the usual care condition will receive jail and community-based behavioral health services.
Existing behavioral health service programs

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptability
Time Frame: Study months 21 through 34
Client Satisfaction Questionnaire-8, Narrative Evaluation of Intervention Interview
Study months 21 through 34

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of Adapted Interventions
Time Frame: Study months 21 through 34
How successfully can the adapted interventions be implemented (Focus Group interviews)
Study months 21 through 34
Fidelity
Time Frame: Study months 21 through 34
DDMI and IGT Adherence Forms
Study months 21 through 34
Substance use
Time Frame: Study months 20 through 30
Addiction Severity Index
Study months 20 through 30
Psychiatric symptoms
Time Frame: Study months 20 through 30
Brief Psychiatric Rating Scale
Study months 20 through 30
Health status
Time Frame: Study months 20 through 30
SF-12
Study months 20 through 30
Service use
Time Frame: Study months 20 through 30
Epidemiological Catchment Area Interview
Study months 20 through 30
Externalizing behaviors
Time Frame: Study months 20 through 30
Triarchic Psychopathy Measure
Study months 20 through 30
Quality of life measure
Time Frame: Study months 20 through 30
Heinrichs-Carpenter Quality of Life Scale, Plus
Study months 20 through 30
Arrest
Time Frame: Study months 20 through 30
Self-report and official jail records
Study months 20 through 30
Treatment preferences
Time Frame: Study months 20 through 30
Visual analog ranking of 8 different aspects of treatment
Study months 20 through 30

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Richard A Van Dorn, Ph.D., RTI International

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 21, 2015

Primary Completion (Actual)

June 30, 2019

Study Completion (Actual)

June 30, 2019

Study Registration Dates

First Submitted

August 10, 2014

First Submitted That Met QC Criteria

August 10, 2014

First Posted (Estimate)

August 12, 2014

Study Record Updates

Last Update Posted (Actual)

March 17, 2020

Last Update Submitted That Met QC Criteria

March 13, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Implementation

Clinical Trials on Dual-diagnosis motivational interviewing (DDMI)

Subscribe